Hepatoprotective properties of a new pyrimidine derivative - L-ascorbate 1-(2-hydroxyethyl)-4,6-dimethyl-1,2-dihydropyrimidine-2-one, synthesized on the basis Xymedon, were assessed in white rats exposed to CCl4. The compound under study administered prior to exposure to CCl reduced the deviation of biochemical parameters from reference values and severity of structural and morphological changes in liver, when compared to the control. Hepatoprotective properties of the studied compound were more pronounced than those of Xymedon.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10517-017-3610-8 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!